PF-06650808

News alerts, weekly reports and conference planners

Company:

Pfizer

Drug class:

Microtubule inhibitor, Notch3-targeted antibody-drug conjugate

NOTCH3 expression	Estrogen Receptor Positive Breast Cancer	NOTCH3 expression	Estrogen Receptor Positive Breast Cancer	PF-06650808 Sensitive: C3 – Early Trials PF-06650808 Sensitive : C3	PF-06650808 Sensitive: C3 – Early Trials PF-06650808 Sensitive : C3
NOTCH3 expression + ER positive + PGR positive	HER2 Negative Breast Cancer	NOTCH3 expression + ER positive + PGR positive	HER2 Negative Breast Cancer	PF-06650808 Sensitive: C3 – Early Trials PF-06650808 Sensitive : C3	PF-06650808 Sensitive: C3 – Early Trials PF-06650808 Sensitive : C3

Associations
(2)